Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Intangibles: 2023-2025

Historic Intangibles for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Sep 2025 value amounting to $120,000.

  • Tonix Pharmaceuticals Holding's Intangibles changed negligibly% to $120,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $120,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $120,000 for FY2024, which is 98.77% down from last year.
  • As of Q3 2025, Tonix Pharmaceuticals Holding's Intangibles stood at $120,000, which was down 0.00% from $120,000 recorded in Q2 2025.
  • Over the past 5 years, Tonix Pharmaceuticals Holding's Intangibles peaked at $10.2 million during Q2 2023, and registered a low of $120,000 during Q2 2024.
  • Its 3-year average for Intangibles is $4.0 million, with a median of $120,000 in 2025.
  • Data for Tonix Pharmaceuticals Holding's Intangibles shows a maximum YoY tumbled of 98.83% (in 2024) over the last 5 years.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's Intangibles (Quarterly) stood at $9.7 million in 2023, then crashed by 98.77% to $120,000 in 2024, then remained steady at $120,000 in 2025.
  • Its Intangibles was $120,000 in Q3 2025, compared to $120,000 in Q2 2025 and $120,000 in Q1 2025.